ANDA 73135, held by Teva Pharmaceuticals USA. Metoclopramide Hydrochloride.
As of Nov 21, 2026, ANDA 73135 (Metoclopramide Hydrochloride), held by Teva Pharmaceuticals USA, was first approved by FDA on Nov 27, 1991, with 10 approved supplements and 0 published complete response letters.
INDICATIONS AND USAGE Diabetic Gastroparesis Metoclopramide injection is indicated for the relief of symptoms associated with acute and recurrent diabetic gastroparesis is in adults. The Prevention of Nausea and Vomiting Associated with Emetogenic Cancer Chemotherapy Metoclopramide injection is indicated for the prophylaxis of vomiting associated with emetogenic cancer chemotherapy in adults. The Prevention of Postoperative Nausea and Vomiting Metoclopramide injection is indicated for the prophylaxis of postoperative nausea and vomiting in those circumstances where nasogastric suction is undesirable in adults.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Nov 27, 1991 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Metoclopramide HydrochlorideEQ 5MG BASE/ML · injectable;injection | Metoclopramide Hydrochloride | Rx |
| Mar 6, 2024 | Supplement 25Labeling · Standard review | Approved | None posted |
| Mar 6, 2024 | Supplement 28Labeling · Standard review | Approved | None posted |
| Sep 19, 2013 | Supplement 19Labeling · Standard review | Approved | None posted |
| Jun 3, 2010 | Supplement 9Labeling | Approved | None posted |
| May 19, 2004 | Supplement 7Labeling | Approved | None posted |
| Aug 22, 2002 | Supplement 5Labeling | Approved | None posted |
| Nov 24, 1999 | Supplement 4Labeling | Approved | None posted |
| Mar 6, 1996 | Supplement 3Labeling | Approved | None posted |
| Jun 2, 1995 | Supplement 2Manufacturing | Approved | None posted |
| Dec 10, 1993 | Supplement 1Manufacturing | Approved | None posted |
| Nov 27, 1991 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. “What FDA's review says” is read by a model (Claude Haiku) from FDA's summary review PDF; a field is shown only if its numbers appear in the review, and each section links the review. Drugs@FDA and FDA complete response letters